Metabolic Syndrome Predicts Chemotherapy Resistance and Poor Prognosis in Epithelial Ovarian Cancer: A Retrospective Observational Cohort Study.

Deng J, Cheng L, Xiang G, Yang Z, Li C, He Y, Chen X

Open source

DOI
10.2147/ijwh.s614197
Published
2026
Container
International journal of women's health
Publisher
Not recorded
Open access
yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

Cite this work

BibTeX

@article{allodium:10.2147/ijwh.s614197,
  title = {Metabolic Syndrome Predicts Chemotherapy Resistance and Poor Prognosis in Epithelial Ovarian Cancer: A Retrospective Observational Cohort Study.},
  author = {Deng J and Cheng L and Xiang G and Yang Z and Li C and He Y and Chen X},
  year = {2026},
  journal = {International journal of women's health},
  doi = {10.2147/ijwh.s614197},
  url = {https://doi.org/10.2147/ijwh.s614197}
}

RIS

TY  - JOUR
TI  - Metabolic Syndrome Predicts Chemotherapy Resistance and Poor Prognosis in Epithelial Ovarian Cancer: A Retrospective Observational Cohort Study.
AU  - Deng J
AU  - Cheng L
AU  - Xiang G
AU  - Yang Z
AU  - Li C
AU  - He Y
AU  - Chen X
PY  - 2026
JO  - International journal of women's health
DO  - 10.2147/ijwh.s614197
UR  - https://doi.org/10.2147/ijwh.s614197
ER  - 

APA

J, D., L, C., G, X., Z, Y., C, L., Y, H., & X, C. (2026). Metabolic Syndrome Predicts Chemotherapy Resistance and Poor Prognosis in Epithelial Ovarian Cancer: A Retrospective Observational Cohort Study.. International journal of women's health. https://doi.org/10.2147/ijwh.s614197

Source records